ANI Refiles Cortrophin After Talks With FDA
Application Turned Down By FDA Last Year
US-based ANI Pharmaceuticals has made manufacturing and API changes as part of its refiled package for Cortrophin Gel (corticotropin) for injection, which it hopes will be a “transformational opportunity.”
